U.S. researchers are about to test if livers from gene-edited pigs could treat people with sudden liver failure — not with a transplant but temporarily attached outside the body WASHINGTON -- U ...

Surgeons have now published the first report of a gene-edited pig liver transplanted into a person. The liver, which came from a genetically modified pig, appeared to stay active, producing bile ...

Doctors in China have become the first to report details about a transplant of a genetically modified pig liver into a human. The liver was transplanted last year into a person who was brain-dead ...

Massachusetts-based researchers will soon test whether livers from a gene-edited pig could treat people with sudden liver failure by temporarily filtering their blood so their own organ can rest ...

The pig liver produced far smaller amounts of bile and albumin than a human liver could achieve, Lin said. More research is needed -- including studying the pig liver for more than 10 days, he added.

Chinese doctors said Wednesday that they had transplanted a liver from a genetically modified pig into a brain-dead human for the first time, raising hopes of a live-saving donor option for ...

The pig liver produced far smaller amounts of bile and albumin than a human liver could achieve, Lin said. More research is needed—including studying the pig liver for more than 10 days, he added.

As part of the trial, people with severe liver failure who are ineligible to receive a human organ will be temporarily connected to an external pig liver that will filter their blood. The trial is ...

Now, a group of doctors and scientists in China report they have done the same with a pig liver. In a study published in Nature, the group describes transplanting a gene-edited pig liver into a ...

Chinese doctors have made a historic breakthrough by successfully transplanting a genetically engineered pig liver into a human. The organ functioned normally for 10 days without immune rejection ...

This photo provided by eGenesis on Jan. 18, 2024 shows a genetically modified pig liver in Massachusetts before transportation to the University of Pennsylvania in Philadelphia in December 2023.